Business Standard

Azad concerned over Indian pharma cos selling-off to MNCs

Press Trust of India  |  Mumbai 

Union Health Minister at a meeting with here today expressed concern over some of the recent sell-off of Indian pharmaceutical companies to foreign multinationals including that of Piramal's Healthcare Solutions business.

"The Minister expressed concern over the trend and raised the issue of the sale of Piramal's domestic formulations unit," industry participants who attended the first zonal meeting for the pharmaceutical companies from the west and southern parts of the country told reporters here.

"Piramal's Healthcare Vice-Chairman Swati Piramal, who also attended the meeting explained that the money generated from the sale is used to strengthen the research and development of the pharma company and that the Piramals hold a majority stake in the company and only a part of the group is sold," they said.

The Union Health Ministry convened a meeting of from the western and southern parts of the country today, in the back drop of rising trend of major Indian being taken over by the MNCs. It was the first of a series of zonal meetings scheduled.

Meanwhile, said that she clarified it to the Minister that the sale of a part of the business helped the company strengthen its future research and development and new drug developments.

In May, US drug major, Abbott India, acquired Piramal's Healthcare Solutions business for an up-front payment of $2.12-billion and an additional $400-million annually for the next four-years.

RECOMMENDED FOR YOU

Azad concerned over Indian pharma cos selling-off to MNCs

Union Health Minister Ghulam Nabi Azad at a meeting with pharma companies here today expressed concern over some of the recent sell-off of Indian pharmaceutical companies to foreign multinationals including that of Piramal's Healthcare Solutions business.

Union Health Minister at a meeting with here today expressed concern over some of the recent sell-off of Indian pharmaceutical companies to foreign multinationals including that of Piramal's Healthcare Solutions business.

"The Minister expressed concern over the trend and raised the issue of the sale of Piramal's domestic formulations unit," industry participants who attended the first zonal meeting for the pharmaceutical companies from the west and southern parts of the country told reporters here.

"Piramal's Healthcare Vice-Chairman Swati Piramal, who also attended the meeting explained that the money generated from the sale is used to strengthen the research and development of the pharma company and that the Piramals hold a majority stake in the company and only a part of the group is sold," they said.

The Union Health Ministry convened a meeting of from the western and southern parts of the country today, in the back drop of rising trend of major Indian being taken over by the MNCs. It was the first of a series of zonal meetings scheduled.

Meanwhile, said that she clarified it to the Minister that the sale of a part of the business helped the company strengthen its future research and development and new drug developments.

In May, US drug major, Abbott India, acquired Piramal's Healthcare Solutions business for an up-front payment of $2.12-billion and an additional $400-million annually for the next four-years.

image
Business Standard
177 22

Azad concerned over Indian pharma cos selling-off to MNCs

Union Health Minister at a meeting with here today expressed concern over some of the recent sell-off of Indian pharmaceutical companies to foreign multinationals including that of Piramal's Healthcare Solutions business.

"The Minister expressed concern over the trend and raised the issue of the sale of Piramal's domestic formulations unit," industry participants who attended the first zonal meeting for the pharmaceutical companies from the west and southern parts of the country told reporters here.

"Piramal's Healthcare Vice-Chairman Swati Piramal, who also attended the meeting explained that the money generated from the sale is used to strengthen the research and development of the pharma company and that the Piramals hold a majority stake in the company and only a part of the group is sold," they said.

The Union Health Ministry convened a meeting of from the western and southern parts of the country today, in the back drop of rising trend of major Indian being taken over by the MNCs. It was the first of a series of zonal meetings scheduled.

Meanwhile, said that she clarified it to the Minister that the sale of a part of the business helped the company strengthen its future research and development and new drug developments.

In May, US drug major, Abbott India, acquired Piramal's Healthcare Solutions business for an up-front payment of $2.12-billion and an additional $400-million annually for the next four-years.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard